MedPath

The interrelationships between changes in the metabolic state and homeostasis of the bone and injection of a new substance during orthodontic tooth movement

Not Applicable
Conditions
Skeletal class II and moderate maxillary protrusion
Musculoskeletal Diseases
Registration Number
ISRCTN99776766
Lead Sponsor
Damascus University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Ongoing
Sex
All
Target Recruitment
40
Inclusion Criteria

1. Patient who has a second class II as light to medium with 42. In the vertical plane, a natural or slight vertical growth pattern
3. Moderate anchorage, where the molar and canine relationships are cusp to cusp
4. The mandibular dental arch is well aligned or slightly crowed and does not require extraction treatment
5. A patient with good oral health and healthy periodontal tissue
6. A patient who does not take any medications
7. A patient who has not undergone previous orthodontic treatment

Exclusion Criteria

1. Patients who have a severe structural defect in the sagittal plane
2. Patients who have a severe horizontal or vertical growth pattern
3. The patient who has moderate to severe crowding in the lower dental arch requires extraction to treat it
4. Patients with general diseases or craniofacial syndromes
5. Pregnant or breastfeeding

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1. The amount of slippage of the upper first molars mesially during retraction<br>2. The inclination of the axes of the upper first molars<br>3. Rotation of maxillary first molars<br>4. The height of the alveolar bone in the injection area<br>5. The thickness of the alveolar bone in the injection area<br>6. Root resorption of maxillary first molars<br>Measured using cone beam computed tomography (CBCT) before the start of orthodontic treatment and after the end of the mass retraction
Secondary Outcome Measures
NameTimeMethod
Pain and discomfort following injection measured using the visual analogue score (VAS) at baseline, 1, 3, and 7 days
© Copyright 2025. All Rights Reserved by MedPath